Clinical Study on Treatment of 78 Cases of Herpes Viral Facial Neuritis by Tube Moxibustion plus Acupuncture

Tian Fengwei; Wang Zhuxing; Lu Yu; et al.

doi:10.13288/j.11-2166/r.2006.04.018

您当前的位置：

首页 >

文章列表页 >

Clinical Study on Treatment of 78 Cases of Herpes Viral Facial Neuritis by Tube Moxibustion plus Acupuncture

更新时间：2021-11-21

- Clinical Study on Treatment of 78 Cases of Herpes Viral Facial Neuritis by Tube Moxibustion plus Acupuncture
- Journal of Traditional Chinese Medicine Issue 4, Pages: 269-271(2006)
- 作者机构：
  
  1. 重庆市中医研究院针灸科
  2. 四川大学华西医院
  3. 重庆市江北区中医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2006.04.018
  CLC： R246
- Published：2006
- 稿件说明：
移动端阅览
[1]田丰玮,王竹行,路瑜,苟春雁,李宁,王红.管灸加针刺治疗疱疹病毒性面神经炎78例临床研究[J].中医杂志,2006(04):269-271.

Tian Fengwei, Wang Zhuxing, Lu Yu, et al. Clinical Study on Treatment of 78 Cases of Herpes Viral Facial Neuritis by Tube Moxibustion plus Acupuncture[J]. Journal of Traditional Chinese Medicine2006, (4): 269-271.
[1]田丰玮,王竹行,路瑜,苟春雁,李宁,王红.管灸加针刺治疗疱疹病毒性面神经炎78例临床研究[J].中医杂志,2006(04):269-271. DOI： 10.13288/j.11-2166/r.2006.04.018.

Tian Fengwei, Wang Zhuxing, Lu Yu, et al. Clinical Study on Treatment of 78 Cases of Herpes Viral Facial Neuritis by Tube Moxibustion plus Acupuncture[J]. Journal of Traditional Chinese Medicine2006, (4): 269-271. DOI： 10.13288/j.11-2166/r.2006.04.018.

摘要

目的:评价管灸加针刺治疗疱疹病毒性面神经炎的临床疗效。方法:3个中心共160例患者入组

157例完成研究。病例随机分为治疗组和对照组

两组均进行基础针刺治疗

在此基础上

治疗组和对照组分别给予管灸治疗和悬灸治疗。观察周期为8周

采用面部残疾指数和面神经功能分级评定疗效。结果:治疗组总有效率91.03%

对照组总有效率72.15%

治疗组疗效明显优于对照组（P<0.05）。两组总体疗效和性别、年龄无明显相关性

但和入组病情轻重有明显相关性（P<0.01）。结论:对于疱疹病毒性面神经炎

管灸加针刺的疗效优于悬灸加针刺的疗效。

Abstract

Objective:To evaluate clinical therapeutic effect of Tube moxibustion plus acupuncture on herpes viral facial neuritis.Methods:One hundred and sixty cases were enrolled in 3 centers.Among them

157 cases completed the study and were randomly divided into a treatment group and a control group.All patients were treated with basic acupuncture therapy

and the treatment group were added with Tube moxibustion and the control group were added with suspended moxibustion.They were treated for 8 weeks and therapeutic effects were evaluated with facial disability index and House-Brackmann scale.Results:After treatment

the total effective rate was 91.03% in the treatment group and 72.15% in the control group

the treatment group being significantly better than the control group（P<0.05）.The total therapeutic effect was not related with sex and age

but it was significantly related with the state of illness before treatment（P<0.01）.Conclusion:The therapeutic effect of Tube moxibustion plus acupuncture is better than that of suspended moxibustion plus acupuncture for herpes viral facial neuritis.

关键词

Keywords

references

查看原文

Views

161

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploration on the Connotation and Application of the Three Aspects of "Dietary Inquiry" for "Appetite" "Eating Capacity" "Food Preference"

WANG Qingguo's Experience in Treatment of Headache Based on the Concept of "Achieving Harmony by Unblocking and Balancing"

Syndrome Differentiation and Treatment of Cholinergic Urticaria from the Perspective of "Treating Fire Constraint by Dispersing It"

Exploring the Comorbidity Mechanism，Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰